TARIS BIOMEDICAL
TARIS Biomedical develops new therapies designed for the treatment of difficult-to-treat bladder diseases. The company's system is designed to continuously release drugs in the bladder over weeks to months and is deployed and retrieved using minimally-invasive, in-office procedures, enabling drug release to be tailored to match the needs of each disease.
TARIS BIOMEDICAL
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2008-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.tarisbiomedical.com
Total Employee:
11+
Status:
Active
Contact:
+1 781 676 7750
Email Addresses:
[email protected]
Total Funding:
113.09 M USD
Technology used in webpage:
SPF Amazon Amazon Virginia Region
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Evrys Bio
Evrys Bio is a pharmaceutical company for providing health care solutions to defend against the virus.
LivWell
LivWell is dispensary company that provides exceptional cannabis products.
Molecular Templates
Molecular Templates develops novel therapeutic compounds for cancer.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Silver Creek Pharmaceuticals
Silver Creek Pharmaceuticals is a biotechnology company, develops protein therapeutics to treat cardiovascular diseases.
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Xeris Pharmaceuticals
Xeris Pharmaceuticals is a pharmaceutical company that develops therapies for patients in endocrinology, neurology, and gastroenterology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Roman Abramovich
Roman Abramovich investment in Series B - TARIS Biomedical
Millhouse
Millhouse investment in Series B - TARIS Biomedical
Flagship Pioneering
Flagship Pioneering investment in Series B - TARIS Biomedical
Polaris Partners
Polaris Partners investment in Series B - TARIS Biomedical
Bristol-Myers Squibb
Bristol-Myers Squibb investment in Series B - TARIS Biomedical
Yonghua Capital
Yonghua Capital investment in Series B - TARIS Biomedical
RA Capital Management
RA Capital Management investment in Series B - TARIS Biomedical
Yonjin Venture
Yonjin Venture investment in Series A - TARIS Biomedical
RA Capital Management
RA Capital Management investment in Venture Round - TARIS Biomedical
Flagship Pioneering
Flagship Pioneering investment in Venture Round - TARIS Biomedical
Official Site Inspections
http://www.tarisbiomedical.com
- Host name: aa089eb6179d1ae2b.awsglobalaccelerator.com
- IP address: 76.223.34.124
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "TARIS Biomedical"
TARIS Biomedical - Crunchbase Company Profile
TARIS Biomedical develops new therapies designed for the treatment of difficult-to-treat bladder diseases. The company's system is designed to continuously release drugs in the bladder over weeks to months and is deployed and …See details»
Taris Biomedical - VentureRadar
TARIS Biomedical LLC was formed as part of the transaction between TARIS Biomedical, Inc., and Allergan in August 2014. This new entity retained the management team, pipeline …See details»
Taris Biomedical LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Taris Biomedical LLC of Lexington, MA. Get the latest business insights from Dun & Bradstreet.See details»
Taris Biomedical (US) - PitchBook
Apr 2, 2013 Taris Biomedical (US) General Information Description. Developer of targeted new therapies designed for the treatment of difficult-to-treat bladder diseases. The company's …See details»
Taris Biomedical - Company Profile - Tracxn
Nov 15, 2024 Taris Biomedical - Drug delivery device for bladder diseases. Acquired by Johnson & Johnson. Raised a total funding of $109M over 6 rounds from 8 investors. Founded by …See details»
TARIS Biomedical - Flagship Pioneering
TARIS Biomedical® was founded in 2008 in response to a long-standing clinical need for a convenient, safe, and effective way to treat bladder disease locally. Encouraged by the …See details»
TARIS Biomedical - Overview, News & Similar companies - ZoomInfo
Dec 20, 2019 Johnson & Johnson (NYSE: JNJ) acquired Taris Biomedical, a privately-owned biotechnology company specializing in the development of a novel drug delivery …See details»
TARIS Biomedical - Org Chart, Teams, Culture & Jobs - The Org
TARIS Biomedical is a leader in the local sustained delivery of therapeutics to the genitourinary system. Industries. Pharmaceutical. Headquarters. Lexington, United States. Stage. Series B. …See details»
TARIS Biomedical Company Profile - Office Locations ... - Craft
TARIS Biomedical was founded in 2008 in response to a long-standing clinical need for a convenient, safe, and effective way to treat bladder disease locally. Encouraged by the …See details»
Johnson & Johnson acquires TARIS Biomedical - 2019-12-20
Dec 20, 2019 TARIS Biomedical TARIS Biomedical is a pharmaceutical company developing therapies for genitourinary system issues. Acquiring Organization: Johnson & Johnson …See details»
TARIS Biomedical - Company Profile & Staff Directory - ContactOut
TARIS Biomedical a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device …See details»
Taris Biomedical - PitchBook
Taris Biomedical is headquartered in Woburn, MA. What is the size of Taris Biomedical? Taris Biomedical has 8 total employees. What industry is Taris Biomedical in? Taris Biomedical’s …See details»
TARIS Biomedical - Contacts, Employees, Board Members
Organization. TARIS Biomedical . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... About. TARIS Biomedical has 4 current employee profiles, …See details»
TARIS Biomedical | Scientist.com
TARIS Biomedical® is a product-focused drug delivery company treating genitourinary conditions with deep domain expertise in the local delivery and sustained release of therapeutics to target …See details»
Johnson & Johnson Acquires TARIS Biomedical with Focus on …
NEW BRUNSWICK, N.J., Dec. 20, 2019 /PRNewswire/ -- Johnson & Johnson announced today the acquisition of TARIS Biomedical LLC (TARIS), a privately-owned biotechnology company …See details»
TARIS Biomedical® Raises $32 Million and… | Flagship Pioneering
Oct 27, 2015 LEXINGTON, Mass.--(BUSINESS WIRE)--TARIS Biomedical LLC, a company using proprietary delivery technology and deep expertise in bladder biology to develop novel …See details»
Johnson & Johnson Acquires TARIS Biomedical ... - Flagship …
NEW BRUNSWICK, NJ, December 20, 2019 – Johnson & Johnson announced today the acquisition of TARIS Biomedical LLC (TARIS), a privately-owned biotechnology company …See details»
TARIS - Janssen
2 days ago A small pretzel-shaped device designed as a novel approach for the treatment of bladder cancer attracted Janssen Oncology to TARIS Biomedical in 2019 and ultimately led to …See details»
TARIS Biomedical LLC | Insights
Oct 8, 2024 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
TARIS Biomedical® Launches Second Phase 1b Clinical Trial of …
Business Wire: August 10, 2016 – LEXINGTON, MA, U.S.A. – TARIS Biomedical, a company developing powerful and targeted new treatments for millions of patients suffering from difficult …See details»